Medpace Holdings, Inc. (MEDP) stock
MEDPNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 22, 2026Score 14/3042% above fair value
$646.87−6.22 (-0.95%)
Close on Nov 18, 2026Market cap $18.09BP/E 35.9Yield –
Medpace market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Medpace's market cap was $18.55B on Nov 11, 2026, against $16.69B a year earlier. Over the last 5 years it ranged from $4.57B to $18.55B, with a median of $9.74B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $18.55B | +17.3% |
| 2025 | Dec 31, 2025 | $15.82B | +53.2% |
| 2024 | Dec 31, 2024 | $10.33B | +9.8% |
| 2023 | Dec 29, 2023 | $9.41B | +42.4% |
| 2022 | Dec 30, 2022 | $6.61B | -15.5% |
| 2021 | Dec 31, 2021 | $7.82B | +57.1% |
| 2020 | Dec 31, 2020 | $4.98B | +64.4% |
| 2019 | Dec 31, 2019 | $3.03B | +60.7% |
| 2018 | Dec 31, 2018 | $1.88B | +38.9% |
| 2017 | Dec 29, 2017 | $1.36B | -7.7% |
| 2016 | Dec 30, 2016 | $1.47B | – |
See a number that looks wrong?